Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Dostarlimab
LB-100
Locations
1
United States
M D Anderson Cancer Center
Houston, Texas, United States
Start Date
November 10, 2023
Primary Completion Date
October 1, 2027
Completion Date
October 1, 2027
Last Updated
December 24, 2025
NCT05281471
NCT04104776
NCT05226507
NCT05415098
NCT02866370
Lead Sponsor
M.D. Anderson Cancer Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions